What it is
PatientSpotlight is an editorial intelligence publication covering nine therapy areas - oncology, rare disease, immunology, neurology, cardiometabolic, respiratory, women's health, mental health, and ophthalmology. It covers the gap between what the science has demonstrated and what the delivery system can actually deliver - across treatments, diagnostics, regulation, payer policy, and the patient experience.
It is not a news site, not a blog, and not a research database. It is a structured intelligence layer organised around four content types that each do a defined job, summarised below.
Who it is for
PatientSpotlight is written for people who need a clear, sourced read on a fast-moving, technically dense field. That includes:
- Patients and families trying to understand a new diagnosis, a treatment recommendation, or what is actually happening in the field - particularly via our Explained primers.
- Clinicians and care teams who want a sourced synthesis of operational and policy questions that the trial literature does not directly answer.
- Pharma commercial, medical, and access teams who need an independent read on rollout dynamics, payer fragmentation, and competitive positioning.
- Investors, analysts, and policy researchers tracking the field for decision-relevant intelligence rather than headline summaries.
- Journalists and other publications looking for a sourced reference layer - citation is welcome.
The four content types
Each piece on the site is one of four kinds:
- Signals - short, dated reads on what is moving. Clinical, regulatory, operational. They name what we know now and what we are watching next; they do not require a take.
- Insights - longer-form synthesis pieces that take a position. Written when the picture is firm enough to commit for the next twelve to twenty-four months.
- Snapshots - dated reference pages. The landscape laid out as it stands today, refreshed when something material moves.
- Explained - plain-language primers on the tests, treatments, and concepts that come up most often. Written so a non-specialist can read once and walk away with a working understanding.
Who runs it
PatientSpotlight is the public surface of PanaceaIntel, the gated editorial intelligence product published by Panacea 85. What you read here is the headline framing. The full brief, the editorial takeaway, the source list, and the discussion prompts live on PanaceaIntel for entitled client teams.
PanaceaIntel is the editorial team behind every Signal, Insight, Snapshot, and Explained piece on the site. The site has no guest contributors and no syndicated content; everything is written and edited in-house.
If you want the full depth - request access to PanaceaIntel. The team replies within one working day.
How it is funded
PatientSpotlight is editorial. There is no paid editorial, no sponsored content, no advertising on the site, and no commercial relationship with any of the developers, sponsors, payers, or institutions covered here. Where commercial relationships exist between PanaceaIntel and any party covered, those relationships are disclosed within the relevant piece.
Operating costs are funded by PanaceaIntel. We do not run a paywall and we do not run a subscription product on this site. That may change in the future; if it does, the change will be announced here and reflected in our editorial policy.
Editorial standards at a glance
Every piece is written from primary sources - FDA labels and approval letters, CMS coverage decisions, peer-reviewed publications, sponsor filings, conference proceedings, and published health-system experience. Each piece is dated. Where evidence is uncertain, the piece says so. Where the picture is changing, the piece names what we are watching. Where we do not yet have a strong view, we publish a Signal - not an Insight.
For the full standards, see our editorial policy; for the working method behind every piece, see our methodology; for the source types we draw from, see our source list; for our data practices, see our privacy page.
How to engage
The most direct way to follow PatientSpotlight is the RSS feed, which carries every new piece in reverse-chronological order. We do not currently operate a newsletter; if and when one launches, it will be opt-in and announced on the site.
For correspondence - interview requests, citations, factual corrections, or commercial enquiries directed at PanaceaIntel rather than at the editorial site - please contact PanaceaIntel directly. We treat factual corrections as a priority and update the affected piece (with the date) when the correction is warranted.
Scope
The current scope spans nine therapy areas: oncology, rare disease, immunology, neurology, cardiometabolic, respiratory, women's health, mental health, and ophthalmology. Coverage is primarily US, with comparative reads of the UK and EU where policy or clinical practice diverges meaningfully. Coverage depth varies by area and is shown on each therapy area hub.